The Science of Altitude Training

The quest to enhance athletic endurance has long driven sports scientists to explore environmental extremes. While deliberate exposure to thin air was recorded among mountaineers in the early twentieth century, the athletic community took serious notice during the 1968 Olympic Games in Mexico City. Situated over 2,200 metres above sea level, the host city saw sprint records tumble while endurance runners struggled significantly against the thinner air. The underlying issue was not a lower percentage of atmospheric oxygen—which remains constant at approximately 21 per cent regardless of elevation—but a dramatic drop in barometric pressure. This phenomenon, known scientifically as hypobaric hypoxia, reduces the partial pressure of oxygen in the atmosphere, thereby limiting the volume of oxygen that diffuses across the lungs into arterial blood.

When the human body encounters such oxygen deprivation, it initiates an intricate cascade of physiological adjustments. The initial compensatory mechanism is a surge in ventilation rate and heart rate, which temporarily stabilises systemic delivery. Within hours of exposure, specialised renal cells detect the drop in renal tissue oxygenation and stimulate the synthesis of erythropoietin, a glycoprotein hormone commonly abbreviated as EPO. Circulating EPO targets the bone marrow, where it accelerates the maturation and proliferation of red blood cells. Over several weeks, this process leads to an expansion of total haemoglobin mass, enhancing the blood's capacity to transport oxygen to contracting skeletal muscle fibres during prolonged exertion.

Early conditioning models relied on a straightforward method termed "live-high, train-high" (LHTH), in which athletes both resided and completed all workouts at mountain retreats. However, coaches and researchers soon discovered that this approach carried hidden disadvantages. While the haematological gains were undeniable, the hypoxic environment imposed severe constraints on physical output. Athletes could not sustain their customary speeds or power outputs during high-intensity intervals, leading to a state of neuromuscular deconditioning. Furthermore, prolonged exposure to high altitude often accelerated muscle catabolism, causing an unintended reduction in lean body mass and blunting the anticipated benefits of the haematological gains.

To resolve this paradox, physiologists developed the "live-high, train-low" (LHTL) protocol during the 1990s. Under this regimen, athletes spend their resting and sleeping hours at moderate altitudes—typically between 2,000 and 2,500 metres—while travelling down to lower elevations or sea level for strenuous training sessions. This split allows them to trigger haematological adaptations without compromising velocity or aerobic power. For athletes who lack geographical access to natural mountains, artificial alternatives such as hypoxic tents or climate-controlled rooms have become popular. These devices manipulate nitrogen levels at sea level to lower the fraction of inhaled oxygen, a condition known as normobaric hypoxia.

Beyond red blood cell mass, altitude exposure stimulates several non-haematological mechanisms that contribute to endurance. Skeletal muscle undergoes metabolic remodelling, including an increase in mitochondrial efficiency, meaning less oxygen is consumed to generate a given amount of adenosine triphosphate. Additionally, altitude conditioning appears to enhance muscle buffering capacity, which is the biochemical ability of muscle cells to neutralise accumulating hydrogen ions during anaerobic glycolysis. This internal buffering delays the onset of muscular acidosis, allowing middle-distance runners and cyclists to sustain near-maximal efforts for longer periods before exhaustion sets in.

Despite these well-documented advantages, the physiological response to altitude is far from uniform. Sports researchers classify athletes into "responders" and "non-responders" based on the degree to which their bodies adapt. One primary determinant of success is the athlete's baseline iron stores. The rapid synthesis of red blood cells requires substantial amounts of elemental iron; if an athlete enters an altitude camp with deficient serum ferritin, EPO production fails to translate into elevated haemoglobin mass. Furthermore, altitude often induces sleep fragmentation and elevated resting metabolic rates, which can precipitate overtraining or immune suppression in susceptible individuals if recovery is not carefully managed.

The timing and duration of altitude exposure are also critical factors in determining performance outcomes. Research suggests that a minimum duration of three to four weeks is required to achieve meaningful erythropoietic changes, provided the daily hypoxic dose exceeds twelve hours. Upon returning to sea level, athletes often experience a temporary peak in performance, but the longevity of these adaptations is limited. A physiological process known as neocytolysis—the selective destruction of young red blood cells in response to a sudden surplus of oxygen—can rapidly diminish newly acquired erythrocyte populations, often returning haemoglobin mass to baseline within a matter of weeks.